DALACIN C

Medicinal product

(Invented) name

DALACIN C

Active substance (s)

Klindamicinas

Strength

300 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G01AA10, Clindamycin

Marketing authorisation holder

UAB Limedika, Lietuva

Date of authorisation

2021-04-19

Date of renewal

Documents

1508-001_DALACIN C_2025-04-08_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

kapsulėje yra	1 vnt.
Klindamicinas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106322	92423	1092423	lizdinė plokštelė	N16		Receptinis	LT/L/21/1508/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-04-19	Registruotas